C12N 2760/12061
Methods of inactivation or attenuation
C12N2760/12061 (Methods of inactivation or attenuation) appears on 4 US grants and 10 published applications in this corpus.
Search patents in C12N- Granted patents
- 4
- Published applications
- 10
- Assignees
- 5
- Inventors
- 20
- Latest grant
- 22 Jan 2019
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2013 | 0 | 2 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 2 | 1 |
| 2017 | 0 | 1 |
| 2018 | 1 | 0 |
| 2019 | 1 | 0 |
| 2020 | 0 | 1 |
| 2021 | 0 | 0 |
| 2022 | 0 | 1 |
| 2023 | 0 | 1 |
| 2024 | 0 | 1 |
| 2025 | 0 | 1 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Methods for viral inactivation and other adventitious agents22 Jan 2019US 10,184,106 B2Genentech, Inc.
- Schmallenberg virus (SBV) vaccine, methods of production, and uses thereof23 Jan 2018US 9,872,897 B2Boehringer Ingelheim Vetmedica GmbH
- Methods for viral inactivation and other adventitious agents15 Nov 2016US 9,493,744 B2Genentech, Inc.
- Schmallenberg virus (SBV) vaccine, methods of production, and uses thereof21 Jun 2016US 9,370,562 B2Boehringer Ingelheim Vetmedica GmbH
- Crimean-congo hemorrhagic fever virus replicon particles and use thereof15 Jan 2026US 2026/0014243 A1The U.S.A., as represented by the Secretary, Department of Health and Human Services
- Methods for viral inactivation and other adventitious agents3 Apr 2025US 2025/0109376 A1Genentech, Inc.
- Methods for viral inactivation and other adventitious agents19 Sep 2024US 2024/0309314 A1Genentech, Inc.
- Methods for viral inactivation and other adventitious agents25 May 2023US 2023/0159886 A1Genentech, Inc.
- Crimean-congo hemorrhagic fever virus replicon particles and use thereof27 Jan 2022US 2022/0023410 A1The United States of America, as represented by the Secretary, Department of Health and Human Servic
Most cited
By later US patents